ESC Premium Access

Manifestations and outcome of severe warfarin overanticoagulation - the EWA study.

Congress Presentation

About the speaker

Doctor Samuli Jaakkola

Turku University Hospital, Turku (Finland)
0 follower

4 more presentations in this session

Discussant: Best Posters in tailoring anticoagulant therapy


Direct factor Xa inhibition prevents cardiac remodeling induced by intermittent hypoxia through PAR-1/2 dual signaling pathway.

Speaker: Miss M. Shimada (Takatsuki, JP)


A patient-specific tailored intervention improves INR time in therapeutic range and INR variability in heart failure patients: A randomized controlled trial

Speaker: Associate Professor I. Gotsman (Jerusalem, IL)


Low TAFI level increases the risk of bleedings in a target INR during long-term warfarin therapy

Speaker: Doctor N. Vorobyeva (Moscow, RU)


Access the full session

Best Posters 6 - Best Posters in tailoring anticoagulant therapy

Speakers: Doctor S. Jaakkola, Miss M. Shimada, Associate Professor I. Gotsman, Doctor N. Vorobyeva

About the event


ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb